Reducing maternal prenatal depression to improve child cardiovascular health

减少母亲产前抑郁症,改善儿童心血管健康

基本信息

项目摘要

PROJECT SUMMARY/ABSTRACT It is critical to understand risk and protective factors for health to optimize developmental outcomes and inform prevention of poor health behaviors across the lifespan. Research using longitudinal designs, multiple levels of analysis, and experimental clinical trials are needed. Cardiovascular disease (CVD) is the leading cause of death worldwide. The origins of adult CVD begin prenatally: High prenatal maternal depressive symptoms robustly predict offspring CVD risk. However, knowledge on risk and protective factors for CVD for offspring of mothers with high depressive symptoms has been correlational. There is a lack of experimental work using a randomized controlled trial (RCT) design to understand potential mechanisms that contribute to children's CVD risk following exposure to high maternal prenatal depressive symptoms across multiple levels (e.g., maternal and child behaviors, physiology) over time. Although efficacious interventions to diminish depressive symptoms among pregnant women exist, research has not investigated whether reducing prenatal maternal depressive symptoms can reduce offspring cardiovascular risk. The current study proposes to leverage a RCT of an effective psychosocial intervention for prenatal maternal depression to test whether reducing prenatal maternal depressive symptoms improves offspring cardiovascular health at ages 3-4 years. We hypothesize that the prenatal intervention operates by reducing both prenatal and postnatal depressive symptoms to improve child outcomes. This study will identify intervention targets for offspring of mothers with high prenatal depressive symptoms to reduce cardiovascular risk. These goals will be accomplished by building on a RCT (R01MH109662) of an established psychosocial intervention that effectively reduces maternal prenatal depressive symptoms. We propose to leverage this unique opportunity to follow up mothers and children who participated in this RCT to test whether this intervention improves offspring cardiovascular health. This project increases rigor of the existing correlational research by using an experimental RCT design. The following 3 aims will be addressed. Aim 1: To test whether reducing prenatal maternal depressive symptoms improves the quality of food the mother feeds her child, maternal feeding behaviors, and modeling of eating behaviors at 3 years. Aim 2: To test whether reducing prenatal maternal depressive symptoms improves child diet, eating behaviors, sleep, and physical activity at 3 years. Aim 3: To test whether reducing prenatal maternal depressive symptoms reduces child CVD risk at 3 and 4 years, including BMI, waist circumference, body fat, blood pressure, and arterial stiffness. This project will provide the strongest evidence to date for a mechanistic model of prenatal maternal depressive symptoms' influence on child cardiovascular health. Importantly, the project will also provide evidence for whether effective psychosocial interventions to reduce prenatal maternal depressive symptoms should be used to reduce the burden of CVD in the next generation.
项目摘要/摘要 了解健康的风险和保护因素至关重要,以优化发展结果并告知 预防整个生命周期的健康行为不良。使用纵向设计,多个级别的研究 分析和实验临床试验。心血管疾病(CVD)是 全球死亡。成人CVD的起源从产前开始:高产前产妇抑郁症状 坚固地预测后代CVD风险。但是,关于CVD的风险和保护因素的知识 具有高抑郁症​​状的母亲是相关的。缺乏实验性工作 随机对照试验(RCT)设计,以了解有助于儿童CVD的潜在机制 暴露于多个级别的高产前产前抑郁症状后的风险(例如 随着时间的流逝,儿童行为,生理学)。尽管有效的干预措施减轻了抑郁症状 在孕妇存在中,研究尚未研究是否减少产前产妇抑郁症 症状可以减少后代心血管风险。当前的研究建议利用 产前孕产妇抑郁症的有效社会心理干预测试是否减少产前产妇 抑郁症状改善了3-4岁的后代心血管健康。我们假设 产前干预通过减少产前和产后抑郁症状以改善儿童而进行 结果。这项研究将确定产前抑郁症高的母亲的后代的干预目标 降低心血管风险的症状。这些目标将通过在RCT上构建来实现 (R01MH109662)已建立的社会心理干预措施,可有效地降低母亲产前 抑郁症状。我们建议利用这个独特的机会来跟进母亲和孩子 参加此RCT,以测试这种干预措施是否改善了后代心血管健康。这个项目 通过使用实验性RCT设计,增加了现有相关研究的严格性。以下3 目标将被解决。目标1:测试减少产前母体抑郁症状是否改善 母亲为孩子喂养的食物质量,孕产妇的喂养行为以及饮食行为的建模3 年。目标2:测试减少产前产妇抑郁症状是否可以改善儿童饮食,进食 行为,睡眠和体育活动3年。目标3:测试是否减少产前产妇 抑郁症状会在3和4年中降低儿童CVD风险,包括BMI,腰围,体内脂肪, 血压和动脉僵硬。该项目将为迄今为止提供最有力的证据 产前产妇抑郁症状对儿童心血管健康的影响的模型。重要的是, 项目还将提供证据证明是否有效的社会心理干预措施减少产前产妇 应使用抑郁症状来减轻下一代CVD的负担。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

Elysia Poggi Davis的其他基金

Group-based Prevention of Postpartum Depression: In-person vs. Virtual Delivery
基于团体的产后抑郁症预防:现场分娩与虚拟分娩
  • 批准号:
    10674881
    10674881
  • 财政年份:
    2022
  • 资助金额:
    $ 58.26万
    $ 58.26万
  • 项目类别:
Group-based Prevention of Postpartum Depression: In-person vs. Virtual Delivery
基于团体的产后抑郁症预防:现场分娩与虚拟分娩
  • 批准号:
    10523797
    10523797
  • 财政年份:
    2022
  • 资助金额:
    $ 58.26万
    $ 58.26万
  • 项目类别:
Reducing maternal prenatal depression to improve child cardiovascular health
减少母亲产前抑郁症,改善儿童心血管健康
  • 批准号:
    10754441
    10754441
  • 财政年份:
    2021
  • 资助金额:
    $ 58.26万
    $ 58.26万
  • 项目类别:
Inflammatory trajectories across pregnancy: Investigating novel markers of risk for postpartum depression
整个怀孕期间的炎症轨迹:研究产后抑郁症风险的新标志物
  • 批准号:
    10408046
    10408046
  • 财政年份:
    2021
  • 资助金额:
    $ 58.26万
    $ 58.26万
  • 项目类别:
Inflammatory trajectories across pregnancy: Investigating novel markers of risk for postpartum depression
整个怀孕期间的炎症轨迹:研究产后抑郁症风险的新标志物
  • 批准号:
    10217881
    10217881
  • 财政年份:
    2021
  • 资助金额:
    $ 58.26万
    $ 58.26万
  • 项目类别:
Reducing maternal prenatal depression to improve child cardiovascular health
减少母亲产前抑郁症,改善儿童心血管健康
  • 批准号:
    10851438
    10851438
  • 财政年份:
    2021
  • 资助金额:
    $ 58.26万
    $ 58.26万
  • 项目类别:
Reducing maternal prenatal depression to improve child cardiovascular health
减少母亲产前抑郁症,改善儿童心血管健康
  • 批准号:
    10543229
    10543229
  • 财政年份:
    2021
  • 资助金额:
    $ 58.26万
    $ 58.26万
  • 项目类别:
Reducing maternal prenatal depression to improve child cardiovascular health
减少母亲产前抑郁症,改善儿童心血管健康
  • 批准号:
    10548740
    10548740
  • 财政年份:
    2021
  • 资助金额:
    $ 58.26万
    $ 58.26万
  • 项目类别:
Reducing maternal prenatal depression to improve child cardiovascular health
减少母亲产前抑郁症,改善儿童心血管健康
  • 批准号:
    10406803
    10406803
  • 财政年份:
    2021
  • 资助金额:
    $ 58.26万
    $ 58.26万
  • 项目类别:
Reducing Fetal Exposure to Maternal Depression to Improve Infant Risk Mechanisms
减少胎儿接触母亲抑郁症的机会,改善婴儿风险机制
  • 批准号:
    9914375
    9914375
  • 财政年份:
    2017
  • 资助金额:
    $ 58.26万
    $ 58.26万
  • 项目类别:

相似国自然基金

成人型弥漫性胶质瘤患者语言功能可塑性研究
  • 批准号:
    82303926
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
  • 批准号:
    82302160
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
  • 批准号:
    82302025
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
  • 批准号:
    82302311
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

The neural underpinnings of speech and nonspeech auditory processing in autism: Implications for language
自闭症患者言语和非言语听觉处理的神经基础:对语言的影响
  • 批准号:
    10827051
    10827051
  • 财政年份:
    2024
  • 资助金额:
    $ 58.26万
    $ 58.26万
  • 项目类别:
Computational and neural signatures of interoceptive learning in anorexia nervosa
神经性厌食症内感受学习的计算和神经特征
  • 批准号:
    10824044
    10824044
  • 财政年份:
    2024
  • 资助金额:
    $ 58.26万
    $ 58.26万
  • 项目类别:
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
  • 批准号:
    10749539
    10749539
  • 财政年份:
    2024
  • 资助金额:
    $ 58.26万
    $ 58.26万
  • 项目类别:
Developing Real-world Understanding of Medical Music therapy using the Electronic Health Record (DRUMMER)
使用电子健康记录 (DRUMMER) 培养对医学音乐治疗的真实理解
  • 批准号:
    10748859
    10748859
  • 财政年份:
    2024
  • 资助金额:
    $ 58.26万
    $ 58.26万
  • 项目类别:
Core B: B-HEARD Core
核心 B:B-HEARD 核心
  • 批准号:
    10555691
    10555691
  • 财政年份:
    2023
  • 资助金额:
    $ 58.26万
    $ 58.26万
  • 项目类别: